Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focusesOn |
molecular diagnostics
CRISPR technology |
| gptkbp:foundedIn |
2018
|
| gptkbp:founder |
gptkb:Feng_Zhang
gptkb:Jim_Collins gptkb:David_Walt |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sherlock Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableFor |
COVID-19 diagnostic tests
developing CRISPR-based diagnostic tests |
| gptkbp:receivedFDAEUA |
2020
|
| gptkbp:technology |
gptkb:INSPECTR_platform
gptkb:SHERLOCK_platform |
| gptkbp:website |
https://sherlock.bio/
|
| gptkbp:bfsParent |
gptkb:Feng_Zhang
|
| gptkbp:bfsLayer |
4
|